Adults with Von Hippel-Lindau disease to benefit from new treatment
NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people.
Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people.
The latest episode of NICETalks focuses on the NICE guideline for management of adrenal insufficiency.
People with adrenal insufficiency should be given an emergency medical kit with potentially life-saving steroid injections, according to our new clinical guideline.
Our draft recommendation follows analysis of clinical trial evidence and reviewing the benefits of slowing disease progression, with the cost of treatment.
Best practice resources for practitioners and commissioners.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
Summaries of evidence and advice on common health topics (CKS)
Join us in our mission to improve the quality of health and social care services. Our committees develop and update our guidance.
They meet over several months and their work is vital in forming our recommendations.
Being a committee member puts you at the heart of our work and helps us make sure that our guidance is relevant to the people that matter.